TASP0415914

CAS No. 1292300-75-4

TASP0415914 ( —— )

Catalog No. M21131 CAS No. 1292300-75-4

TASP0415914 is an orally potent inhibitor of phosphoinositide 3-kinase γ (PI3Kγ).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 132 Get Quote
5MG 222 Get Quote
10MG 357 Get Quote
25MG 597 Get Quote
50MG 851 Get Quote
100MG 1152 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TASP0415914
  • Note
    Research use only not for human use.
  • Brief Description
    TASP0415914 is an orally potent inhibitor of phosphoinositide 3-kinase γ (PI3Kγ).
  • Description
    TASP0415914 is an orally potent inhibitor of phosphoinositide 3-kinase γ (PI3Kγ).
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3Kγ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1292300-75-4
  • Formula Weight
    323.37
  • Molecular Formula
    C13H17N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(=O)Nc1nc(C)c(-c2nc(N3CCCC(O)C3)no2)s1
  • Chemical Name
    N-{5-[3-(3-hydroxypiperidin-1-yl)-124-oxadiazol-5-yl]-4-methyl-13-thiazol-2-yl}acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oka Y Yabuuchi T Oi T et al. Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-124-oxadiazol-5-yl]-4-methyl-13-thiazol-2-ylacetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases[J]. Bioorganic & Medicinal Chemistry 2013 21(24):7578-7583.
molnova catalog
related products
  • PI3K-IN-16

    PI3K-IN-16 is a potent and selective, orally bioavailable PI3Kβ and PI3Kδ inhibitor.

  • Copanlisib dihydroch...

    Copanlisib dihydrochloride is an ATP-competitive pan-class I PI3K inhibitor (IC50s: 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ).

  • APY0201

    APY0201 is a potent, highly selective, ATP-competitive PIKfyve inhibitor (IC50=5.2 nM) that interrupts the conversion of phosphatidylinositol 3-phosphate (PtdIns3P) to PtdIns(3,5)P2.